Skip To Main Content

Transplantační medicína

Nejnovější trendy

Prozkoumejte nejčtenější články a videa na Campus Sanofi

Seřadit

Taming Diabetes: A Daily Challenge for Martin and His Family

Taming Diabetes: A Daily Challenge for Martin and His Family

Follow 8-year-old Martin and his family as they navigate daily life with type 1 diabetes, from meal adaptations to school activities, showing resilience and optimism.

Living with T1D for 25 Years: Philippe's Inspiring Journey

Living with T1D for 25 Years: Philippe's Inspiring Journey

At the dawn of his fifties, Philippe has tamed the diabetes he has lived with for over 25 years, along with his initial fear of injections. For him, this disease represents "a turning point, not an end." He leads a life "like everyone else," multiplying passions and fully enjoying every moment.

Research Review Product Summary

Research Review Product Summary

Gla-300 in patients with type 2 diabetes mellitus: Sustained glycaemic control with lower risk of hypoglycaemia and observed lower weight gain  

How to inject Toujeo (insulin glargine 300U/mL)

How to inject Toujeo (insulin glargine 300U/mL)

Educate your patients on correct injection technique for Toujeo

Switching to Toujeo® (insulin glargine 300 units/mL) from other regimens

Switching to Toujeo® (insulin glargine 300 units/mL) from other regimens

A clinical guide for healthcare professionals on switching patients to Toujeo® (insulin glargine 300 units/mL) from other insulin regimens.

Toujeo: Insulin Naive start Guide

Toujeo: Insulin Naive start Guide

Insulin is one of the most effective glucose-lowering agents for type 2 diabetes and can be titrated to suit an individual patient’s requirements.

Seznam PCSK9i center

Seznam PCSK9i center

V tomto článku se dozvíte, kde najít seznam všech PCSK9i center.

DUPIXENT® - WISSEN kompakt

DUPIXENT® - WISSEN kompakt

Age-Related Risk Factors for IMD: From Infants to Elderly

Age-Related Risk Factors for IMD: From Infants to Elderly

Comprehensive overview of age-specific risk factors for Invasive Meningococcal Disease (IMD), detailing vulnerability patterns across different life stages. Features specific risks for infants, adolescents, and elderly populations, including the impact of maternal antibody decline, nasopharyngeal colonization, and immunosenescence in older adults.

Protecting Pilgrims: Meningococcal Disease Risk Factors During Mass Gatherings

Protecting Pilgrims: Meningococcal Disease Risk Factors During Mass Gatherings

Comprehensive analysis of meningococcal disease risk factors during mass religious gatherings, with focus on the Hajj pilgrimage. Details environmental challenges, demographic vulnerabilities, and transmission dynamics among pilgrims, local residents, and healthcare workers in Mecca, with emphasis on crowded conditions and N. meningitidis carriage rates.

Age and Serogroup Patterns: IMD in South Africa

Age and Serogroup Patterns: IMD in South Africa

Comprehensive analysis of Invasive Meningococcal Disease (IMD) patterns in South Africa, featuring GERMS-SA surveillance data from 2018-2024. Highlights age-specific incidence rates, with detailed focus on infant vulnerability (1.6 per 100,000) and adolescent/young adult peaks. Includes serogroup distribution trends across the country.